Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.

Medical Mycology

Volumn 48, Issue 5, 2010, Pages 720-724

  Simitsopoulou, Maria ^a   Georgiadou, Elpiniki ^a   Walsh, Thomas J ^b   Roilides, Emmanuel ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antifungal agents; Cytokines; Human neutrophils; Zygomycetes

Indexed keywords

CASPOFUNGIN; INTERLEUKIN 6; INTERLEUKIN 8; POSACONAZOLE; TUMOR NECROSIS FACTOR ALPHA; VORICONAZOLE; 2,3-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-5-((PHENYLAMINO)CARBONYL)-2H-TETRAZOLIUM HYDROXIDE; ANTIFUNGAL AGENT; ECHINOCANDIN; PYRIMIDINE DERIVATIVE; TETRAZOLIUM; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; CUNNINGHAMELLA BERTHOLLETIAE; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS ISOLATION; HUMAN; NEUTROPHIL; NONHUMAN; RHIZOPUS; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; CELL CULTURE; CUNNINGHAMELLA; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; SECRETION (PROCESS);

CUNNINGHAMELLA; CUNNINGHAMELLA BERTHOLLETIAE; RHIZOPUS; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; ZYGOMYCETES;

ADULT; ANTIFUNGAL AGENTS; CELLS, CULTURED; CUNNINGHAMELLA; ECHINOCANDINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MICROBIAL VIABILITY; NEUTROPHILS; PYRIMIDINES; RHIZOPUS; TETRAZOLIUM SALTS; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA; VORICONAZOLE;

EID: 77954785960     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903476635     Document Type: Article

References (15)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
2. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215-229.
3. Pyrgos V, Shoham S, Walsh TJ. Pulmonary zygomycosis. Semin Respir Crit Care Med 2008; 29: 111-120.
4. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917. (Pubitemid 34229758)
5. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350-1360.
6. Gil-Lamaignere C, Simitsopoulou M, Roilides E, et al. Interferongamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 2005; 191: 1180-1187. (Pubitemid 40404378)
7. Meshulam T, Levitz SM, Christin L, Diamond RD. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2- methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis 1995; 172: 1153-1156.
8. Ma LJ, Ibrahim AS, Skory C, et al. Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication. PLoS Genet 2009; 5: e1000549.
9. Lamaris GA, Ben-Ami R, Lewis RE, et al. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fl y and murine models of zygomycosis. J Infect Dis 2009; 199: 1399-1406.
10. Choudhary MI, Jalil S, Musharraf SG. Fungal transformation of dydrogesterone and inhibitory effect of its metabolites on the respiratory burst in human neutrophils. Chem Biodivers 2008; 5: 324-331.
11. Peracoli MT, Kurokawa CS, Calvi SA, et al. Production of pro-and anti-infl ammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect 2003; 5: 413-418.
12. Antachopoulos C, Demchok JP, Roilides E, Walsh TJ. Fungal biomass is a key factor affecting polymorphonuclear leukocyteinduced hyphal damage of filamentous fungi. Mycoses 2009; PMID: 19638003.
13. Roilides E, Dimitriadou-Georgiadou A, Sein T, Kadiltsoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998; 66: 5999-6003.
14. Brieland JK, Jackson C, Menzel F, et al. Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun 2001; 69: 1554-1560.
15. Walsh TJ, Roilides E, Cortez K, et al. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Med Mycol 2005; 43 (Suppl. 1): S165-172.